Gieselmann V, Zlotogora J, Harris A, Wenger D A, Morris C P
Institut für Biochemie II, Georg-August-Universität Göttingen, Germany.
Hum Mutat. 1994;4(4):233-42. doi: 10.1002/humu.1380040402.
Metachromatic leukodystrophy is an autosomal recessive inherited lysosomal storage disease. It can be caused by mutations in two different genes, the arylsulfatase A and the prosaposin gene. These genes encode two proteins that are needed for the proper degradation of cerebroside sulfate, a glycolipid mainly found in the myelin membranes. Deficiency of arylsulfatase A or of a proteolytic product of prosaposin leads to the accumulation of cerebroside sulfate, which causes a lethal progressive demyelination. Mutations in the arylsulfatase A gene are far more frequent than those of the prosaposin gene. So far 31 amino acid substitutions, one nonsense mutation, three small deletions, three splice donor site mutations, and one combined missense/splice donor site mutation have been identified in the arylsulfatase A gene. Two of these mutant alleles are frequent, accounting for about one-half of all mutant alleles, whereas the remainder are heterogeneous. Amino acid substitutions cluster in exons 2 and 3, a region that shows a high degree of conservation among sulfatases of different function and origin. Different mutations are associated with phenotypes of different severity, but there is a remarkable variability of severity when patients with identical genotypes are compared. Demonstration of an arylsulfatase A deficiency is not a proof of metachromatic leukodystrophy, since a substantial deficiency without any clinical consequences is frequent in the general population. This deficiency is caused by an arylsulfatase A allele, which due to certain mutations encodes greatly reduced amounts of functional enzyme. However, these amounts are sufficient to sustain a normal phenotype. In the diagnosis and genetic counseling, these deficiencies must be differentiated from those causing metachromatic leukodystrophy. So far only six patients with mutations in the prosaposin gene have been described, in which three defective alleles two with amino acid substitutions and one with a 33-bp insertion have been identified.
异染性脑白质营养不良是一种常染色体隐性遗传的溶酶体贮积病。它可由两种不同基因的突变引起,即芳基硫酸酯酶A基因和prosaposin基因。这些基因编码两种蛋白质,它们是脑硫脂正常降解所必需的,脑硫脂是一种主要存在于髓鞘膜中的糖脂。芳基硫酸酯酶A或prosaposin蛋白水解产物的缺乏会导致脑硫脂的蓄积,从而引起致命的进行性脱髓鞘。芳基硫酸酯酶A基因的突变比prosaposin基因的突变更为常见。到目前为止,在芳基硫酸酯酶A基因中已鉴定出31个氨基酸替代、1个无义突变、3个小缺失、3个剪接供体位点突变和1个错义/剪接供体位点联合突变。其中两个突变等位基因较为常见,约占所有突变等位基因的一半,其余则是异质性的。氨基酸替代集中在外显子2和3中,该区域在不同功能和来源的硫酸酯酶之间具有高度保守性。不同的突变与不同严重程度的表型相关,但在比较相同基因型的患者时,严重程度存在显著差异。芳基硫酸酯酶A缺乏的证明并不意味着就是异染性脑白质营养不良,因为在普通人群中,相当数量的缺乏但无任何临床后果的情况很常见。这种缺乏是由一个芳基硫酸酯酶A等位基因引起的,由于某些突变,该等位基因编码的功能酶量大大减少。然而,这些量足以维持正常表型。在诊断和遗传咨询中,必须将这些缺乏与导致异染性脑白质营养不良的缺乏区分开来。到目前为止,仅描述了6例prosaposin基因发生突变的患者,其中已鉴定出3个缺陷等位基因,2个为氨基酸替代,1个为33bp插入。